cagrilintide and tirzepatide together combination trial Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study CagriSema vs cagri and tirzepatide together 🔬

Olatorepatide obesity treatment licensed by Regeneron demonstrates positive phase 3 results in Chinese patients

Helps maintain skin's natural elasticity, promotes firmness and youthful appearance, supports healthy collagen production, and aids the overall skin repair process

Mechanistically, its claimed effects track the biology of that TB4 motif: regulating actin dynamics, driving cell migration, and supporting new vessel growth and tissue repair

The recommended dosage for Tirzepatide is as follows: 2.5 mg once weekly for the first 4 weeks 5 mg once weekly for at least 4 weeks If additional glycemic control is needed, then the dosage can be increased by 2.5 mg after at least 4 weeks on the current dose The maximum dose is 15mg once weekly Tirzepatide should be dosed subcutaneously

The suit alleges that Lilly's campaigns across television and social media are harmful because consumers often rely on advertising to form their understanding of GLP-1s, unlike healthcare professionals, who have access to the full scientific evidence available